Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
101 hedge funds and large institutions have $749M invested in Epizyme, Inc in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 17 closing their positions.
96% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $1.16M
48% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 27
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less funds holding
Funds holding: 104 → 101 (-3)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
35% less capital invested
Capital invested by funds: $1.15B → $749M (-$402M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$10.4M |
| 2 |
BlackRock
New York
|
+$8.43M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$7.27M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$6.72M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$38.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.7M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.24M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.98M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$4.53M |
EPZM Hedge Fund Activity: Q4 2017 in Review
101 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2017, worth a combined $749M — down 35% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of EPZM and 15 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 40 added.
The largest buyer was Redmile Group, adding an estimated $10.4M. The largest seller was Fidelity Investments, cutting an estimated $38.3M.
- 101 institutional investors held Epizyme, Inc (EPZM) as of Q4 2017, down from 104 in Q3 2017.
- Funds reported $749M of Epizyme, Inc stock for Q4 2017, down 35% quarter-over-quarter.
- 15 funds opened new Epizyme, Inc positions in Q4 2017 and 17 closed out, a net change of -2 holders.
- The largest Epizyme, Inc buyer in Q4 2017 was Redmile Group, an estimated $10.4M added.
- The largest Epizyme, Inc seller in Q4 2017 was Fidelity Investments, an estimated $38.3M sold.
Based on aggregated 13F filings for Q4 2017.